HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Adamoli Selected Research

Estrogen Receptors

10/2012Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.
9/2012Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laura Adamoli Research Topics

Disease

13Breast Neoplasms (Breast Cancer)
06/2015 - 02/2006
8Neoplasms (Cancer)
09/2014 - 11/2006
3Disease Progression
11/2012 - 11/2007
2Circulating Neoplastic Cells
09/2014 - 10/2010
1Rectal Neoplasms (Rectal Cancer)
09/2014
1Neoplasm Metastasis (Metastasis)
01/2014
1Triple Negative Breast Neoplasms
08/2013
1Hypertension (High Blood Pressure)
08/2013
1Brain Neoplasms (Brain Tumor)
01/2013
1Cardiovascular Diseases (Cardiovascular Disease)
11/2012
1Pain (Aches)
11/2006
1Lymphangitis
11/2006

Drug/Important Bio-Agent (IBA)

3Trastuzumab (Herceptin)FDA Link
02/2014 - 01/2012
2Vinorelbine (Navelbine)FDA LinkGeneric
06/2015 - 02/2006
2Capecitabine (Xeloda)FDA Link
06/2015 - 02/2006
2AntigensIBA
02/2014 - 10/2010
2Progesterone Receptors (Progesterone Receptor)IBA
01/2014 - 10/2012
2Hormones (Hormone)IBA
02/2013 - 01/2012
2Estrogen ReceptorsIBA
10/2012 - 09/2012
2Fulvestrant (Faslodex)FDA Link
09/2012 - 11/2007
1Bevacizumab (Avastin)FDA Link
06/2015
1EstramustineFDA Link
02/2015
1Neoplasm Antigens (Tumor Antigens)IBA
02/2014
1AntibodiesIBA
02/2014
1Cancer VaccinesIBA
02/2014
1human ERBB2 proteinIBA
01/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2013
1Therapeutic UsesIBA
08/2013
1Antihypertensive Agents (Antihypertensives)IBA
08/2013
1thiamine triphosphorate (TTP)IBA
11/2012
1Epidermal Growth Factor (EGF)IBA
10/2012
1Phenobarbital (Luminal)FDA Link
10/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2012
1Methotrexate (Mexate)FDA LinkGeneric
09/2012
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2006
1Morphine (MS Contin)FDA LinkGeneric
11/2006
1ErbB Receptors (EGF Receptor)IBA
11/2006
1Analgesics (Analgesic Drugs)IBA
11/2006
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2006
1Tyrosine Kinase InhibitorsIBA
11/2006

Therapy/Procedure

6Therapeutics
06/2015 - 01/2012
5Drug Therapy (Chemotherapy)
06/2015 - 11/2006
1Neoadjuvant Therapy
09/2014
1Immunotherapy
02/2014
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2014
1Radiotherapy
01/2013
1Subcutaneous Mastectomy
11/2006
1Adjuvant Chemotherapy
11/2006